INTRODUCTION
The incidence of syphilis in Europe has declined in the last decade'. In England and Wales 4069 cases of syphilis were reported to the Communicable Disease Surveillance Centre in London in 1980, compared to 1305 in 1990. In the USA the number It has not been possible to distinguish this organism in vitro from the other pathogenic treponemes: T. pallidum subspecies pertenue, the causative agent of yaws; T. pallidum subspecies endemicum, the causative agent of endemic syphilis; and T. pallidum subspecies carateum the causative agent of pinta.
Only limited replication of T. pallidum has been achieved in cell culture systems. At present, this is not a practical technique for cultivating organisms for study or diagnostic purposes. The organism is usually cultivated in rabbits or guinea pigs for research.
T. pallidum is a thin, spiral organism, with 4 to 14 turns, 0.1 to 0.15 pm in diameter and 8 to 12/tm in length. There is some evidence that T. pallidum possesses a capsule overlying the outer membrane which contains a lipid bilayer with a low protein content. A flagellum, consisting of a basal body, and a hook and shaft, arises from each end of the organism and lies beneath the outer membrane. It runs along the length of the axis in the periplasm, overlapping the flagellum from the opposite end. The flagella surround the peptidoglycan layer which covers the cytoplasmic membrane. The cytoplasmic filament is associated with the outer flagella but lies within the cell's cytoplasms. There is a vaguely defined knob structure at each tip", A variety of treponemal antigens have been described, defined by immunoblotting, radioimmunoprecipitation, and immunoelectrophoresis". Extracellular T. paliidum derived antigens and host derived antigens, for example rheumatoid factor, have been reported", A number of important outer membrane proteins, called treponemal membrane protein (Tmp) are defined by molecular weight: 47kDa; 44.5 kDa (TmpA); 34 kDa (TmpC); 28-34 kDa (TmpD); and 15.5 kDa 6 . There are at least 6 flagellar polypeptides''. Differences in proteins from different treponemal species have been described, but have not been found consistentlyv'". A plasmid has been described which suggests a potential for treponemes to acquire genes coding for antibiotic resistance from other organisms!', In the late 194Os, it was estimated from rabbit inoculation studies that the replication time of T. pallidum is between 30 and 33 h in early syphilis12, 13 . It is thought that the organism replicates more slowly in latent or late disease.
Pathology
T. pallidum probably gains access to the body via minute abrasions of the skin or mucous membranes. Its subsequent attachment to host cells involves the action of a rnucopolysaccharidase/-l". It can be found within epithelial cell nuclei in lesions of early syphilisl" as well as within a wide variety of other host cells!". In vitro host cells with large numbers of T. pallidum attached to them may remain viable's but morphological disruption and lysis of such cells has been reported".
Histological examination of a chancre shows endothelial cell thickening with perivascular aggregation of lymphocytes, plasma cells, macrophages and mucoid material which contains hyaluronic acid and chondroitin sulphate. Treponemes can be found lying within endothelial cells-'. The inflammatory response results in a breakdown of ground substance between cells and the loss of integrity and collapse of blood vessels. Dissemination of T. pallidum has occurred at the time of the chancre's appearance, and the organism can attach to red blood cells via immune adherence antibody-s. The lesions of secondary syphilis have the histological features of a vasculitis, accompanied by perivascular white cell infiltration, although immune complex disease is responsible for at least some of the manifestationslv,
Neuropathology
In vitro, attachment of T. pallidum to cultured neurones is followed by disruption of cell morphology and cellular dysfunction-I-l". In vivo, T. pallidum has been found within axons of cutaneous nerves in chancres-". Organisms are present in the cerebrospinal fluid (CSF) of 15-40% of patients with early syphilis 20 , 21 and yet only 10% of patients~o on to develop neurosyphilis if left untreated 2. Meningitic and neurovascular syphilis and general paresis all have common histopathological features, that is the thickening of the blood vessel intima, thinning of the media and perivascular white cell infiltration-V", Different degrees of ischaemia and white cell infiltrate may result in the different pathological varieties of neurosyphilis. Inflammatory change and fibrosis near the spinal nerve roots have been described in the early pathology of tabes dorsalis->,
Immunology
The immune response to T. pallidum in early syphilis reflects the summation of stimulatory and suppressive signals 14 . T. pallidum may initially evade host defences because of the relatively inert nature of the treponemal surface-s. Non-specific mechan~sms may contribute to the elimination o~T. p~l/ldum from the site of inoculation, such as ingestion by macrophages-" and the action of defensins 27 • 28 . In a simplified picture of the immunological response to early syphilis, macrophages and other antigenpresenting cells process and present treponemal antigens to T-helper lymphocytes, which in turn secrete lymphokines such as interleukin-2 (IL-2) to up-regulate the T-Iymphocyte response". Treponemes are opsonized by specific neutralizing antibodies which facilitate their ingestion and destruction by activated macrophages. This leads to the rapid clearance of most bacteria at the primary site of infection. In spite of this, dissemination of low numbers of treponemes to peripheral sites takes place-". Immunity to reinfection does develop.
Rabbits infected with T. pallidum are immune to rechallenge after 12 weeks even if they are treated subsequently with penicillinvt. In the Sing Sing Prison study, prisoners who were inoculated with virulent T. pallidum and then treated a few months later appeared to be immune to reinfection on rechallenge 40 .
Serum antibodies produced as a response to T. pallidum may be used for diagnostic purposes. There is at least one report of neutralizing antibodies developing as a result of T. pallidum infection-". This may be the same antibody that inhibits T. pallidum breakdown of mucopolysaccharide-". The serum antibodies which are detected in diagnostic tests for syphilis are not implicated in bacterial neutralization14.
There are a number of theories as to why T. pallidum might persist in spite of the immunological response and even after penicillin treatment. Many authors describe an immunosuppressive stage in secondary syphilis involving interference with cellmediated immunity in spite of high antitreponemal antibody titres". 'Host-derived immune disguise' substances may be present on the treponemal surface 31.32. Antigens may be concealed within immunologically inert compounds on the surface of the treponeme such as mucopolysaccharides or membrane lipids 33.34. Others suggest an immunoprotective niche-" or a failure to trigger the oxidative metabolic burst in macrophages-".
The Oslo natural history study of over 1000 untreated early syphilitics followed for 30-50 years showed that 60% did not progress beyond the early stages-'. The manifestations of tertiary syphilis in those whose disease progresses may be due in part to a hypersensitivity response 37.38 , although T. pallidum themselves have been found in gummata-".
DIAGNOSIS
A description of the clinical features of syphilis is outside the scope of this article. In primary and secondary syphilis, the diagnosis can be confirmed by demonstrating T. pallidum in exudate from skin lesions using dark-field microscopy'! or a fluorescein labelled monoclonal antibody'<. In a research setting the organism can be definitely identified following inoculation into rabbits-", and more recently the polymerase chain reaction has been used!", In the clinical situation tests for reaginic antibodies (Venereal Disease Research Laboratory (VORL) and Rapid Plasma reagin (RPR» are usually performed quantitatively in serial2-fold dilutions to give a titre. This avoids the possibility of false-negative results due to the prozone phenomena and is used to monitor the response to treatment. The fluorescent treponemal antibody absorption (FTA-Abs) test is a highly sensitive and specific test of the presence of specific treponemal antibody, but is timeconsuming to perform. Other tests such as the T. pallidum haemagglutination assay (TPHA) are used commonly for screening, and confirmed by the FTA-Abs if positive.
It has been accepted that all patients with secondary syphilis, without HIV disease, have positive syphilis serology. However, in a recent series from London, 2.6% of patients with secondary syphilis did not show serum treponemal antibodies, and up to 3.4% did not show reaginic antibodies-a. It is possible that some of these patients might have had HIV disease. Seronegative secondary syphilis has been described elsewhere where HIV was unlikelyw. A number of causes of biological false positive treponemal and non-treponemal serological tests have been described41.45.46. In serum, Western blot had a specificity of 91% and a sensitivity of 90% compared to the FTA-Abs and the Microhaemagglutination assay for T. pal/idum (MHA-TP)47.
NEUROSYPHILIS
Confirmation of the diagnosis of neurosyphilis, or its exclusion, in a patient with positive serological tests for syphilis can be difficult. In the absence of contamination with blood, a positive VDRL on CSF confirms the diagnosis of neurosyphilis. The VORL is negative, however, in a significant proportion of patients with neurosyphilis". Abnormalities of protein and cellular content of the CSF demonstrate inflammation, but are not specific to syphilis. The rabbit inoculation test (RIT) can detect as few as 10 organisms, but is not suitable for routine diagnostic use 21. Thirty percent of patients with primary and secondary syphilis harbour T. pallidum in the CSF21, and 25% of patients with primary and secondary syphilis produce treponemal antibodies intrathecally''". Moreover, T. pallidum can be cultivated from the CSF of 15 to 30% of patients with early syphilis who have otherwise normal CSF20.21. It is not known if these patients are at risk of subsequently developing neurosyphilis. Antibody of the IgG class reactive in the FTA-Abs test can cross the blood-brain barrier in non-inflamed meninges-". The presence of such antibody in the CSF does not therefore demonstrate intrathecal synthesis. Parallel testing with RIT confirmed the CSF FTA-Abs to be a more sensitive detector of the presence of T. pallidum than the VORL. The polymerase chain reaction (PCR) used on CSF has a sensitivity of 47% and specificity of 93% in detecting T. pallidum from previous treponemal infection'". PCR had a sensitivity of 60% and a specificity of 100% compared to the RITfor detecting T. pallidum in the CSF of neonates'".
Neurosyphilis presenting classically as general paresis (GPI) or tabes dorsalis is still described'<. Hooshmand et al., however, proposed that modified neurosyphilis is a clinical entity in which signs of neurological involvement are sparse and atypical 53. In their study the CSF FTA-Abs was used as the 'gold standard' for detection of infection. Reaginic tests were only positive in the CSF of 57% of cases. In Burke's series of 20 patients with classical neurosyphilis, 13 had negative CSF VDRL tests 54 .
Escobar found 100% correlation between the CSF VORL and FTA-Abs in patients without syphilis and with neurosyphilis. One of 34 patients with hitherto undiagnosed syphilis had a positive CSF FTA-Abs as compared to none of 34 for the VORL55. Similar results were obtained by Jaffe et al., who suggested that a reactive FTA-Abs in the CSF in isolation may be due to leakage from the serum into the CSF via a damaged blood-brain barrier's. Another study using carefully defined criteria for 'likely' neurosyphilis found that 4 of 15 patients had a positive CSF VORL, but all of 15 had a positive CSF FTA-Abs 57. A further study on CSF showed the RPR test card to be less specific (85%) and less sensitive (40%) than the VORL (99.8% and 50% respectively) at detecting neurosyphilis'". Luger and colleagues concluded that in the CSF, the TPHA was as sensitive as the FTA-Abs 49.
Biological false positive reagin tests in the CSF may result from tuberculous, pyogenic or aseptic meningitis 59,6o. As little as 0.003 ml blood in a traumatic spinal tap, which is just detectable to the naked eye, can produce a false positive VORL61. An even smaller, visibly undetectable volume of blood can cause a false positive FTA (unabsorbedjs-. In summary, a negative CSF TPHA or FTA-Abs excludes neurosyphilis, but a positive in either test does not necessarily imply the presence of neurosyphilis. A positive CSF VORL confirms neurosyphilis, but a negative test does not exclude it.
Various immunoglobulin indices have been used to assess whether antibody reactive in the FTA-Abs test is present in CSF due to transudation or to intrathecal synthesis. To do this, the relative concentrations of proteins in the CSF and serum are compared, to assess the function of the blood brain barrier. The IgG index is a measure of perivascular inflammation in the close proximity of the CSF and is not specific for syphilis'". The TPHA index relates the function of the blood brain barrier to T. pallidum antibodies. This was above 100 in 10 of 11 patients with active and untreated neurosyphilis. It correlated extremely highly with the results of the CSF-IgM solid haemabsorption assay". In another study, the mean TPHA IgG titre per milligram IgG index of the CSF compared with serum, was high in 86 of 139 patients with untreated neurosyphilts'v. High mean values in this test correlated with the presence of oligoclonal bands in the CSF64, and suggested that in a sizeable minority of patients with clinical neurosyphilis, there is no active intrathecal treponemal immunoglobulin production'". Van Eijk and colleagues, using a similar index showed high intrathecal levels of anti-treponemal antibodies in the CSF of 20 of 21 patients with neurosyphilis, and 17 of 159 patients with late latent syphilis 48. It was suggested that such local antibody production may represent a scar syndrome in the presence of cured infection rather than active disease'<. Muller and colleagues reported that the concentration of anti-treponema] IgM, detected by an ELISA technique, was greater in the CSF than in the serum of 19 patients with untreated neurosyphilis, but not in controls without neurosyphilis'".
HIV AND SYPHILIS
Syphilis and other sexually transmitted diseases are recognized as cofactors for the acquisition and transmission of HIV 66. Abnormal humoral responses may be a result of defective Band T lymphocyte function in patients with HIV67,68. Serum reagin titres may be higher than expected in the presence of HIV69-71. Conversely, there are reports of false negative treponemal and reaginic serology in secondary syphilis in the presence of HIV69,n,73.
Where there is an antibody response to T. pallidum, the range of antibodies demonstrated on Western blot may be qualitatively less than usual?", In patients with a past history of either treated or untreated syphilis, treponemal serology (in some cases both TPHA and FTA-Abs) can revert to negative in the presence of HIV, particularly in those with low T4/T8 ratios and advanced HIV disease 7s, 76 . Therefore, more reliance should be placed on histopathology, dark field microscopy and direct immunofluorescence of skin lesions, particularly in diagnosing secondary syphilis. The serum reaginic and treponemal antibodies usually become positive a number of weeks after presentation of initially seronegative secondary syphilis 69,73. Atypical dermatological presentations of syphilis in the presence of HIV disease have been described, including gummata in secondary syphilis 69. n.
Cases have been reported in which patients co-infected with HIV have failed to respond to treatment for early syphilis and progressed rapidly to tertiary neurosYfahilis, usually vascular or meningeal disease 7o. 78-0. Severe syphilitic encephalitis and arteritis occurred in an HIV-positive individual, in whom the CSF reagin test remained negative'". In a study of 829 patients with AIDS, only 1.5°1?~ad typical clinical or CSF features of n~~rosyp~Il~s:8. Ocular disease in the form of uveitis, papillitis, vitreitis, optic neuritis and retinitis has been described in HIV infected patients 74,n.82.83.
BIOPHARMACOLOGY WITH SPECIAL REFERENCE TO PENICILLIN
During treponemal cell wall synthesis, cross links are formed between N-acetyl muramic acid groups through the action of transpeptidases. The carbon atom on the seventh position of the beta-lactam ring acts as a competitive inhibitor, becoming tightly bound to the enzyme 84 . Proteins which bind penicillin have been identified in T. pa/lidum 85 . It has been suggested that penicillin will only be effective against actively-replicating organisms which are constructing new cell walls'", but it is possible that non-replicating organisms are affected because of a need to continually repair and replace cell wall components between divisions'". T, paitidum has. however, been shown to remain virulent "her incubation with high concentrations of penicillin for up to 72h 86.
Bactericidal penicillin concentrations
The activity of penicillin has been assessed with different methods of assay. A concentration of betw.een 0.001 and 0.003 Itg/ml of penicillin is reqUlr~d to reduce the mobility of a suspension of T, pallidum to 50% after 18 h incubation'". In cell culture~he minimal inhibitory concentration (MIC) was e~t~mated to be 0.0005 Itg/ml and the minimal bact~nCldal co~ce~tration (MBC) 0.0025Ilg/mI89. In rabbit serum, In Vitro clearance levels are estimated at between 0.005Ilg/ml and O.Olllg/ ml penicillin?'. For treatment, the WHO has recommended a minimum serum level of 0.018Ilg/ml (0.03 units/ml) h~c~provid~s .a 4~to 7-fold safety margin for individual variation m pharmacokinerics'".
The rate at which T. pallidum is im.mmobilized in vitro increases in proportion to the penicillin concentration until a plateau is reached at a concentration of 0.1Ilg/mI88. In the rabbit model of syphilitic orchitis, the plateau is reached at a p~nicillin concentration of 0.36 Itg/ml of serum. EIght days appears to be the optimum. length of time for treatment of early rabbit syphilis with penicillin.
Serum, brain and CSF penicillin levels uccessful treatment of syphilis depends on achievmg adequate tissue levels of antibiotic for a duration sufficient to eliminate the organism. An intact immune system may be essential for cure to occur". In early disease, with rapidly dividing treponemes, at least 8 days treatment is necessary to ensure clinical cure'". Benzathine penicillin 2.4 mega units is recommended as treatment for early syphilis 41,93. However, subtreponemicidal serum levels «0.018Ilg/ml) have been found between 3 and 6 days after this dosage 94-96, and are more likely to occur in younger patients'". 600,000 units of procaine penicillin daily, however, appe~r~!o give consistently adequate peak serum penicillin levels 97-99 .
It would be anticipated that penetration of penicillin into nerve tissue is necessary to prevent and treat neurological disease. Levels of penicillin within the CSF are not synonymous with brain tissue levels. But, if neurological disease occurs as the result of endarteritis and periarteritis, it may only be necessary to achieve consistently treponemicidal concentrations of antibiotic in the plasma to frevent the development of neurological disease 23 ,2 • Not surprisingly, there are few studies of penicillin levels in human brain tissue after parenteral administration. Wellman and colleagues obtained brain tissue at prefrontal leucotomy in patients with uninflamed meninges. No penicillin was detected in brain tissue obtained 4 or 24 h after an intramuscular injection of 600,000 units of procaine penicillin100. Kramer and colleagues took brain tissue from epileptics who had received 3.2 million units of parenteral penicillin G 1-4 h earlier. The concentration of penicillin was 23 times greater in the blood than the brain tissuel'".
Penetration of penicillin into the CSF can be increased by fever 102 , although fever therapy is no longer undertaken. Probenecid increases the half life of penicillin in the brain and serum/", When the blood brain barrier is defective, as in meningitic, meningovascular or paretic states, there is leakage of penicillin into the CSF104. Thus, as little as 200,000 units of penicillin daily for 30 days can successfully treat some patients with GPF05. Benzathine pencillin consistently fails to produce treponemicidal levels in the CSp94,%,106. Procaine penicillin 600,000 units daily only infrequently produces treponemicidal levels in CSF97-99, but doses of 1.8 and 2.4 million units daily, with probenecid 500 mg 6-hourly, have been shown to produce treponemicidal CSF levelsl'". Another group found subtreponemicidal levels of penicillin in the CSF of 17/40 patients within 24 h of receiving 2.4 million units procaine penicillin, with probenecid 500 mg 4 times dail yl08. It is possible that higher levels would have.b:~n obtained after a few days of treatment, as penicillin would accumulate within the CNS when a steady state was reached. Intravenous penicillin G, in doses between 5 and 24 million units daily, consistentp roduces a treponemicidal CSF concentration96,99, 1 as does 500,000 units procaine penicillin and probenecid 500 mg e-hourlyt?".
CLINICAL TREATMENT STUDIES
The aim of treating syphilis is to obtain a cure, which may be defined in clinical, serological or microbiological terms. Clinical cure of early syphilis implies the disappearance of lesions. Tissue destruction in tertiary syphilis is a consequence of endarteritis, and may result in residual scarringU'', Early treatment trials assessed cure on clinical grounds and the results of serological tests after therapy. A reanalysis in 1985 of the original data of the multicentre, multitreatment study in the USA, first reported in 1972 111 , looked at the reagin response after treatments of primary and secondary syphilis-". Changes in the VORL titre were plotted against time since treatment for each regimen, and mean rates of decrease were determined. The titre fell 4-fold in the 3 months after treatment and 8-fold at 6 months. The number of patients whose reagin titres fell more slowly than the 95th centile during follow-up was calculated. This occurred in 7% of patients treated with benzathine penicillin 2.4 million units, 16% of those treated with erythromycin, 46% of those treated previously for syphilis and 89% of those whose treatment was a clinical failure.
In a recent study from India the VORL titre fell more quickly in patients treated for primary or secondary syphilis than at a later stage of disease 1l3 . The RPR is usually more sensitive than the VORL. Thus, in a study of early syphilis in Canada, 72% of patients with primary syphilis and 56% patients with secondary syphilis were RPR negative 36 months after treatment with 2.4 million units benzathine penicillin114. This is a lower rate of seroreversion than that reported with the VDRL111,112. In the Canadian study, the FTA-Abs became negative in 24% patients treated for their first attack of syphilis compared with the microhaemagglutination test in which 13% patients seroreverted114.
Biological cure, meaning total eradication of T. pallidum may be impossible even where clinical cure has taken place. Dunlop reviewed studies, of both treated and untreated patients, in which viable organisms persisted in various sites, including the anterior chamber of the eye, the endolymph and the CSF. In the immunocompetent patient persistence of these organisms does not necessarily mean that clinical cure has not been achieved. It is likely that these organisms are replicating slowly and their eradication would therefore require prolonged courses of treatment'P".
Penicillin
No other antibiotic yields lower failure rates than penicillin and none can be given in depot form like penicillin. Patients with seropositive primary syphilis treated with 2.4 or 2.5 million units of benzathine penicillin intramuscularly had a cumulative retreatment rate, representing either reinfection or treatment failure, of 4% over an observation period of 12-21 monthsl15,116. The retreatment rates for secondary syphilis were between 4% and 5.5%. Another study assessing primary and secondary syphilis together showed the cumulative retreatment rate after 2.5 million units of benzathine penicillin to be 5% at 12 months and 11.4% at 24 monthsl!'.
There are a number of anecdotal reports of treatment failures in early syphilis when only 2.4 million units of benzathine penicillin was used ll7 -1l9. Fiumara followed patients with early syphilis treated with a second dose after one week to give a total dosage of 4.8 million units of benzathine penicillin. He excluded from his final analysis patients who had a 4-fold or greater increase in reagin titres after treatment, which he thought was due to reinfection rather than relapse. All of 588 patients with primary syphilis had negative serum reagin tests a year after treatment, as did 623 patients with secondary syphilis after 2 years 120. In another smaller study, 40 patients treated for secondary syphilis with a total of 6 million units of benzathine penicillin over 6 to 10 days all had negative reagin tests by 2 years 121.
Although anecdotal experience in the UK suggests that intramuscular aqueous procaine penicillin is highly successful in the treatment of early syphilis, little in the way of good scientific data is available to back this up. In a review article, Elliot discussed the use of aqueous procaine penicillin for the treatment of primary syphilis with total doses ranging from 4.2 to 15 million units in a total of 381 patients. The mean cumulative retreatment rate, over a period of uf: to 11 years was less than 1% (range 0% to 4%) 22. Another study of patients with primary or secondary syphilis, reported a cumulative retreatment rate of 3.8% at 12 months and 10.7% at 24 months for an 8-day course of 0.6 million units procaine penicillin dail yll2. It is possible that many of the patients retreated at 24 months were reinfected.
Other tJ-Iactam antibiotics
In a T. pallidum immobilization assay, amoxycillin at a concentration of 0.42 J.tg/ml has activity equivalent to penicillin 0.018 J.tg/ml, which is the minimum treponemicidal concentration recommended by the WHOl23. In a rabbit orchitis model the equivalent level of amoxycillin was assessed as O.11Ilg/m}l24. Administration of 2 g amoxycillin with probenecid 500 mg produced a mean serum concentration of amoxycillin of 4 J.tg/ ml after 8 h125. Administration of 3 g amoxycillin with 1 g probenecid produced a mean serum concentration of 10.311lg/ml at 8 h 126. In patients with latent syphilis, the mean trough CSF level of amoxycillin on the second day of treatment with 2 g amoxycillin 8-hourly and 500 mg probenecid 6-hourly was 0.32J.tg/ml 124. In another study, 7 patients were treated with 1 g amoxycillin 6 times a day, with 500mg probenecid 4 times a day. The lowest trough CSF levels was 0.5 J.tg/mP23. Thirty patients with primary and secondary syphilis were successfully treated with a 4-week course of oral amoxycillin, 250 mg 6-hourly. No patient required retreatment in the 2 years of follow Up127.
Ceftriaxone, a third generation cephalosporin, has been investigated over the last few years as a potential treatment for syphilis. The serum half-life following intramuscular administration is approximately 8 h 128. The MIC and 50% T. p~llidum immobilization concentrations have been estimated as 0.0006J.tg/ml and O.OlJ.tg/ml respectively129,130. The mean trough CSF level of ceftriaxone was 0.018 J.tg/ml in rabbits treated with 7.5 mg/kg 12hourly for 7-10 d ays129. In that experiment, T. pallidum remained present in the brain of one of 8 ceftriaxone-treated rabbits, but none of 8 treated with penicillin. In a rabbit model of cutaneous syphilis, the 50% curative dose for ceftriaxone was 0.96 mg/kg per day over 5 days compared to 0.29 mg/kg for penicillin. The authors concluded that ceftriaxone was sli §htly less effective than intravenous penicillin GIl.
Cefmetazole, a cephamycin type antibiotic, has been shown to beas effective as standard benzathine penicillin for the treatment of active syphilis in the rabbit modeP32.
In clinical studies, an intramuscular bolus of 125 mg of ceftriaxone has been used to treat incubating syphilis. Twenty-five of 27 patients exposed to infectious syphilis did not~o on to develop early syphilis after 3 months''' . In the same study, treatment of primary or secondary syphilis resulted in clinical cure in all of 10 patients who received ceftriaxone 250 mg daily for 10 days as well as all of 6 patients who received 500 mg on 5 alternate days. Reagin titres fell at the same rate as in patients treated with penicillin. Two smaller studies showed that 1 g ceftriaxone given on 4 alternate days was successful in the treatment of 14 patients with primary or secondary syphilts-" and 2 g daily for 2 or 5 days was successful in the treatment of primary syphilis135.
Tetracyclines
In a tissue culture system the MICs and MBCs of tetracycline hydrochloride for T. pallidum were assessed at 0.2 j.tg/ml and 0.5 j.tg/ml respectively". Street strains remain as sensitive to tetracyclines as the laboratory Nichols' strainl'". Aureomycin and terramycin have to be taken 6-hourly but penetrate into the CSF and brain 1OO. Doxycycline gives substantially higher levels in brain and CSF than oxytetracycline and tetracycline 137,138. In 5 patients taking doxycycline 200mg daily, the mean CSF level was 1.3 j.tj?jml, with the lowest CSF level at 0.8/Lg/mP39. Tetracycline hydrochloride in a total dose of 30 g was used to treat patients with primary or secondary syphilis. The cumulative retreatment rate was 9.2% at one year and 12.7% at 2 yearsl". In a small study, 200 mg doxycycline daily for 28 days with repeat courses 3-4 times over a year gave a 90% and 100% clinical success rate for the treatment of primary and secondary syphilis respectivelyw'.
Macrolides
In an in vitro cell culture system both the MICs and MBCs of erythrom~cin for T. pallidum were estimated as 0.005 JLg/ml 9. In a rabbit model using Nichols' strain of T. pallidum, the median time for lesions to become dark-field negative was significantly greater for rabbits treated with erythromycin than with benzathine penicillin-", Furthermore, erythromycin does not penetrate well into the CNS1oo,141.
In primary syphilis, cumulative retreatment rates of up to 37% were reported following the use of 1-2 g erythromycin per day122. Doses of 2 and 3 g a day of erythromycin base for 10 days gave cumulative retreatment rates of 26.8% and 10.9% at one year, and 29.9% and 21.3% at 2 years respectivelyl!". A number of clinical failures in the treatment of early syphilis have been reported following the use of erythromycin 136,143-145. A strain of T. pallidum obtained from a patient with secondary syphilis in whom treatment with erythromycin failed, was found to show resistance to erythromycin and roxithromycin136.
The new macrolide antibiotic azithromycin has a longer half-life and much greater tissue penetration than erythromycin. However, the erythromycinresistant strain of T. pallidum was also resistant to azithromycin'P. In a rabbit syphilis model, azithromycin in doses of 7.5 to 30 mg/kg/day was compared to benzathine penicillin 200,000 units weekly for 2 weeks. Lesions became dark-field negative in the penicillin-treated rabbits earlier than in the azithromycin-treated rabbits 146. 5piramycin strongly inhibits both street and Nichols' strains of T. pallidum but clindamycin does not have such activity in either strain136.
Other antibiotics
Ofloxacin seems to have no effect on incubating syphilis in the rabbit modeP47. In rabbits with syphilis, quinolones take significantly longer to cure chancres than penicillin, but, the decrease in reagin titres following treatment with high dose norfloxacin was equivalent to that following treatment with penicillmr". The ineffectiveness of spectinomycin in treating syphilis is apparently due to poor tissue penetration rather than lack of bactericidal activity'".
Treatment of latent syphilis
Most studies on the treatment of latent syphilis are flawed by inadequate definitions and the use of multiple regimens149. Fiumara, using the same criteria for reinfection as in primary and secondary syphilis, followed 368 patients with early latent syphilis after giving 4.8 million units of benzathine penicillin. Ninety-five per cent of the patients had negative reagin tests by 2 years and 100% at 4 years 150. In the series of Talwar et al. 10% to 15% of patients with early latent syphilis had reactive reagin tests 30 months after treatment with 2.4 million units of benzathine penicillin-P. Only 3 of the original 1188 patients had an abnormal CSF at 30 months after treatment. Using aqueous procaine penicillin at a total dose ranging from 3 to 12 million units, none of 209 patients with latent syphilis reported by the WHO had clinical progression or abnormal CSFs at 3 to 12 years after treatment?'. Fiumara, using the same treatment and criteria for cure as for other stages, found 56% of 209 patients with late latent syphilis remained reagin positive after 5 years 151.
Treatment of neurosyphilis
The minimum dose of penicillin which is clinically effective for treating neurosyphilis is not clearly defined. The types and dosages of penicillin used have varied between studies, and criteria for outcome and duration of follow up have not been uniform. In addition, the clinical efficacy of penicillin in different clinical states is not easy to determine152.
In general, treatment is less successful when parenchymal tissue destruction has taken place, as in GPI or tabes dorsalis, than in meningovascular and meningitic diseasell'', The goal of therapy should be to halt disease progression, although at least some degree of the deficit may improvef'. In 21% of patients treated for asymptomatic neurosyphilis with 2.4 million units benzathine penicillin abnormalities were still present in the CSF after 18 monthsl'". Aqueous procaine penicillin given to a total of 20 to 40 million units in 89 patients with neurosyphilis resulted in the resolution of raised CSF cell counts and protein concentrations in all cases. Nevertheless, there was relentless clinical progression in 5 cases of GPI or organic brain syndrome. In another study, treatment of 11 patients with tabes dorsalis and/or meningovascular syphilis with a total of 40 million units of aqueous procaine penicillin, was followed by resolution of CSF changes and clinical improvement'".
In conclusion, benzathine penicillin should not be used to treat any type of neurosyphilis. Intramuscular administration of either 1.8 or 2.4 million units of aqueous procaine penicillin daily or penicillin G 0.5 million units 6-hourly is considered satisfactory if accompanied by concurrent probenecid 500 mg 6-hourly and continued for 21 days. Intravenous treatment can be given with a total of 12 to 24 million units penicillin G per day for the same periodv-109. Doxycycline 200 mg to 400 mg per day for 28 days can be used as a substitute in penicillin allergic patients. Ceftriaxone 1 g a day for 14 days has also been used153.
Treatment of syphilis in patients with HIV
There are several anecdotal reports of treatment failure and accelerated development of neurological or ocular disease following the use of benzathine penicillin to treat patients with syphilis and HIV 78-BO,82. Lukehart and colleagues reported that virulent T. pallidum remained in the CSF of 3 HIVpositive men following treatment for early syphilis with benzathine penicillin 2.4MU, despite improvement in protein and VORL levels in the CSF21. It is prudent therefore to use a treatment regimen suitable for neurosyphilis in HIV infected patients. Careful monitoring is required after treatment, with repeat CSF examination to confirm that neurological cure is established and maintained.
THE JARISCH-HERXHEIMER REACTION
A large proportion of patients with early syphilis have a Jarisch-Herxheimer reaction (JHR) a few hours after the initiation of treatment. The ]HR is characterized by fever, malaise and exacerbation of skin manifestations. It occurs in other spirochaetal diseases and may be fatal in patients with borreliosis154.
A number of studies have attempted to define the mechanisms underlying this reaction. The role of endotoxin has been reconsideredl'f but largely discountedl'v. Activation of extravascular complement has also been proposedl'", but again not confirmed by others l54. Release of tumour necrosis factor and other lymphokines correlates with the reaction and can account for most of its features 158. It is possible that a deficienc~of endogenous opioids is a contributory factor 1 9. The severity of the reaction may be related to the rate of release of the therapeutic agent into tissues and bacteria and its speed of treponemicidal action152. The ]HR occurred in 26% of patients with secondary syphilis treated with benzathine penicillin156 compared to 65% of those treated with the faster released aqueous procaine penicillins".
Treatment of cardiovascular syphilis has been associated with 'therapeutic shock', although there are few documented cases of angina, congestive cardiac failure or changes in murmurs occurring as part of the ]HR 160. In active neurosyphilis the ]HR is of later onset and more prolonged, and the maximum temperature lower than that in early syphilis. The symptoms of dementia, psychosis, meningismus and cranial nerve lesions may worsen in 2% of patients l60. The JHR occurred in all of 3, 12 of 20 and none of 10 patients who were pregnant and had treatment for primary, secondary and latent syphilis respectively. In these cases the JHR was associated with fever, increased uterine contractions and decreased fetal movements, fetal heart abnormalities and intrauterine death161.
Systemic steroids may alleviate the fever but little else in the ]HR. Such treatment has been recommended for use in the ]HR associated with cardiovascular and neurosyphilis 160. Meptazinol, a partial opioid antagonist was given intravenously in a dose of 300-500 mg to patients being treated for louse-borne relapsing fever. In this study the clinical severity of the JHR was reduced, whilst naloxone and steroids had no measurable effect 162. It is advisable to monitor the initiation of treatment for cardiovascular and neurosyphilis closely in case a JHR develops.
ALLERGIC REACTIONS TO PENICILLIN
In patients reporting penicillin allergy skin tests can be performed to assess the risk ?f an adverse reaction. IgE-mediated adverse reactions occurred in 0.45% of 3996 patients who had no history of penicillin allergy and negative skin tests. In comparison, despite negative skin tests, adv~rse reactions occurred in 2.4% of those who gave a history of rash following previous penicillin treatment, in 7.8% of those reporting urticaria and 15.4% of those reporting anaphylaxis. Adverse reactions to penicillin are more likely with parenteral rather than oral treatment, with longer rather than shorter courses and with benzathine rather than other penicillins'<'. Desensitization can be carried out even in patients with past histories of severe reactions to penicillin. This may be particularly important for pregnant women, in whom tetracyclines are contra-indicated and erythromycin is of doubtful efficacy. Desensitization is initiated with small doses of oral penicillin, doubling the dose every 15 minutes for 3 to 4 h. This enables full intravenous therapy to be given subsequently without anaphylaxis developing and with a low incidence of other allergic reactions l 64-166. AURAL SYPHILIS Disease of the inner ear can be found in congenital and acquired syphilis. Syphilis causes chronic osteomyelitis of the temporal bone with miliary gummata and obliterative endarteritis I67 ,168. Typical motile T. pallidum that fluoresce on addition of fluorescence labelled syphilitic serum have been found in the perilymph in such cases l 67 . Patients with positive serological tests for syphilis who have sensorineural deafness should be treated for syphilis, although not all such patients will have active syphilis l 69 ,170. In the majority of patients with otosyphilis the CSF is normalv". Benzathine penicillin has been advocated as treatment for otosyphilis, but it would seem more logical to use one of the high dose regimens suitable for neurosyphilis, to ensure tissue penetrationl'". A number of reports suggest that prednisolone, in doses of 30 mg to 40 mg per day should also be given. Where symptoms and audiometry show improvement over one to 4 weeks, it is suggested steroid therap~should continue for up to 5 months or longer l7l -1 4. Alternate-day prednisolone and ACTH have been used in an attempt to minimize adrenal inhibition171,172. Moderate improvements have, been reported, with speech discrimination responding more than the pure tone threshold. Audiological involvement occurred with asymptomatic neurosyphilis in 5 HIV-positive patients. Symptoms improved in 2 of them following intravenous penicillin treatmentl"'.
IMMUNIZAnON
Numerous investigators have attempted to immunize rabbits and other animals with killed or attenuated T. pallidum. In most ins~ances the re~ults h~ve been disappointing. The antigens on w~Ich an Immt:tnization could be based and which would grve protection have yet to be defined. Suggested sites and antigens for this role include those deep within the treponemes, and heat stable or labile poly-saccharides176.
It is conceivable that vaccination might lead to disease, as gummata can result from inoculation of virulent treponemes into humans who already have tertiary syphilisj". Partially successful inoculation could result in modification and lack of recognition of clinical syphilis if it was subsequently acquiredv", In the most successful vaccination experiment so far, rabbits were inoculated with 3.7x 10 9 gamma irradiated T. pallidum, Nichols strain, over a 37 week period. There was complete protection to rechallenge with 1000 and 100,000 organisms at 37 weeks, and to 1800 organisms at one year l 77 . Other animal vaccines, including those using the Tmp B antigen showed complete immunity in some animals and partial in others I 78 ,179. CONCLUSIONS Like most other venereal diseases, syphilis is a chronic infection. Clinical cure is usually obtained after penicillin treatmen~in im~u~ocompetent patients, although bactenal eradication may not occur. Concern about atypical syphilis occurring in patients co-infected with HIV has led to a reevaluation of diagnostic methods, treatment regimens and follow-up protocols for syphilis. Although the prevalence of syphilis in the UK and the rest of Europe is low at present, the recent increase in the incidence of syphilis in the USA suggests we can only afford to forget this infection at our peril. 
